Protara Therapeutics (TARA) Return on Capital Employed Growth (5y) (2019 - 2026)
Protara Therapeutics (TARA) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Protara Therapeutics | 236.48 Mn | 236.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,706.00 |
| Dec 31, 2025 | -2,147.00 |
| Sep 30, 2025 | -2,042.00 |
| Jun 30, 2025 | -222.00 |
| Mar 31, 2025 | 2,302.00 |
| Dec 31, 2024 | 33,687.00 |
| Sep 30, 2024 | 5,881.00 |
| Jun 30, 2024 | 4,315.00 |
| Mar 31, 2024 | 3,333.00 |
| Sep 30, 2023 | 2,797.00 |
| Jun 30, 2023 | 2,346.00 |
| Mar 31, 2023 | 3,290.00 |
| Sep 30, 2022 | 7,423.00 |
| Jun 30, 2022 | 6,323.00 |
| Mar 31, 2022 | 4,976.00 |
| Sep 30, 2021 | 3,341.00 |
| Jun 30, 2021 | 2,505.00 |
| Mar 31, 2021 | 1,844.00 |
| Dec 31, 2020 | 1,434.00 |
| Sep 30, 2020 | 318.00 |